Articles

Joint media release between Australian Border Force and Therapeutic Goods Administration

Some retailers try to use disclaimers like 'for research purposes only' to sell an illegal product, but these disclaimers don't change the law.

Case studies in Incident Report Investigations; review of reusable biopsy forceps devices; care required with patient lifters

The TGA has launched a web hub to help consumers and health professionals find information on transvaginal (urogynaecological) surgical mesh.

New warning labels for neuromuscular blocking agents; local anaesthetic systemic toxicity; off-label use of atropine

Georgia's story explains how to spot the warning signs for the breast implant associated cancer BIA-ALCL.

TGA issues advertising direction

Today we celebrate the official launch of the TGA Facebook page

The TGA completed a desktop review of selected listed sunscreen products.

Be aware of cross-reactivity with home-use self-test ovulation kits, TGA undertakes product safety review into intragastric balloon systems

Our annual survey measures satisfaction with a range of services and activities including our role and performance

Apalutamide (Erlyand) is the first medicine approved via ACSS Consortium’s NCE working group

Consumers can now report dodgy ads for medicines and medical devices through a single online form

Oral methotrexate dosing, medicines associated with a risk of neuropsychiatric adverse events, and clozapine and gastrointestinal effects

Caitlin's story explains how a patient in Australia can legally access medicinal cannabis.

List of OTC codeine-containing products moving to prescription only

How TGA uses joint replacement registry data; Focus on skills for vacuum-assisted births; TGA reviews product safety of ventilators

This instrument applies to an application to list a complementary medicine under section 26AE of the Act.

This instrument applies to an application to list a medicine under section 26 or 26A of the Act.

This instrument applies to an application to register a complementary medicine

This instrument applies to the online form titled Prescription Medicines Designation/Determination Application in the TGA's electronic lodgement facility, completed in accordance with the relevant instructions in that form.

Therapeutic Goods (Provisional Determinations and Orphan Drug Designations-Extension) Approval of Application Form

Information about influenza vaccines for use in 2018

In reference to the ABC’s Fact Check article “Will the move to make codeine prescription-only save a100 lives a year” the Therapeutic Goods Administration (TGA) would like to clarify:

First-generation oral sedating antihistamines – use in children, Suvorexant (Belsomra) – next day effects, Desvenlafaxine (Pristiq) recommended dose, Miconazole and potential interaction with warfarin